TELA Projected Dividend Yield
TELA Bio Inc ( NASDAQ : TELA )TELA Bio is a medical technology company focused on providing soft-tissue reconstruction solutions that support clinical outcomes by focusing on the preservation and restoration of the patient's own anatomy. Co.'s first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), engages in hernia repair and abdominal wall reconstruction by combining the benefits of biologic matrices and polymer materials. In addition, Co. has also designed an OviTex product specifically for use in laparoscopic and robotic-assisted hernia repair, which it markets as OviTex LPR. Co.'s second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, engages in plastic and reconstructive surgery. 20 YEAR PERFORMANCE RESULTS |
TELA Dividend History Detail TELA Dividend News TELA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |